We are live on ! Find out more
CRL icon

Charles River Laboratories

252 hedge funds and large institutions have $3.49B invested in Charles River Laboratories in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 77 increasing their positions, 109 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more call options, than puts

Call options by funds: $999K | Put options by funds: $464K

26% more capital invested

Capital invested by funds: $2.77B → $3.49B (+$714M)

8% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 24

1% less funds holding

Funds holding: 255252 (-3)

1.43% less ownership

Funds ownership: 100.05%98.62% (-1.4%)

29% less repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 109

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
252
Holders Change
-3
Holders Change %
-1.18%
% of All Funds
6.72%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.11%
New
26
Increased
77
Reduced
109
Closed
24
Calls
$999K
Puts
$464K
Net Calls
+$535K
Net Calls Change
-$5.16M
Name Holding Trade Value Shares
Change
Change in
Stake
CSS
176
Cubist Systematic Strategies
Connecticut
$540K +$84K +1,340 +19%
URS
177
Utah Retirement Systems
Utah
$528K
CIC
178
Cornercap Investment Counsel
Georgia
$508K
AG
179
Aperio Group
California
$508K +$98.4K +1,569 +24%
US Bancorp
180
US Bancorp
Minnesota
$463K +$49.8K +795 +12%
WG
181
Winton Group
United Kingdom
$461K -$808K -12,888 -64%
HIM
182
Hillsdale Investment Management
Ontario, Canada
$458K
SCM
183
Stevens Capital Management
Pennsylvania
$446K +$440K +7,013 New
AIP
184
Ameritas Investment Partners
Nebraska
$440K
TRCT
185
Tower Research Capital (TRC)
New York
$425K +$400K +6,378 +2,105%
WCM
186
Wedge Capital Management
North Carolina
$414K -$56.4K -900 -12%
SAM
187
Securian Asset Management
Minnesota
$413K -$6.27K -100 -2%
QI
188
Quotient Investors
New York
$407K -$194K -3,100 -33%
EIM
189
Essex Investment Management
Massachusetts
$394K
CAM
190
Capstone Asset Management
Texas
$392K -$16.3K -260 -4%
BF
191
BOK Financial
Oklahoma
$373K -$252K -4,017 -41%
SB
192
Suntrust Banks
Georgia
$347K -$4.51K -72 -1%
PAM
193
Princeton Alpha Management
New Jersey
$332K -$31.2K -497 -9%
BA
194
Bridgewater Associates
Connecticut
$331K +$62.7K +1,000 +24%
CB
195
Commerce Bank
Missouri
$322K +$21.2K +338 +7%
BOH
196
Bank of Hawaii
Hawaii
$319K
SCM
197
Shelton Capital Management
Colorado
$306K -$43.9K -700 -13%
SG Americas Securities
198
SG Americas Securities
New York
$297K -$1.07K -17 -0.4%
LPL Financial
199
LPL Financial
California
$286K -$1.82K -29 -0.6%
LIM
200
Leavell Investment Management
Alabama
$286K +$31.3K +500 +13%

CRL Hedge Fund Activity: Q4 2014 in Review

252 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2014, worth a combined $3.49B — up 26% from $2.77B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new CRL positions and 24 closed out — a net gain of 2 holders — while 77 added to existing stakes and 109 trimmed.

The largest buyer was First Trust Advisors, adding an estimated $77.7M. The largest seller was Wellington Management Group, cutting an estimated $16.6M.

  • 252 institutional investors held Charles River Laboratories (CRL) as of Q4 2014, down from 255 in Q3 2014.
  • Funds reported $3.49B of Charles River Laboratories stock for Q4 2014, up 26% quarter-over-quarter.
  • 26 funds opened new Charles River Laboratories positions in Q4 2014 and 24 closed out, a net change of +2 holders.
  • The largest Charles River Laboratories buyer in Q4 2014 was First Trust Advisors, an estimated $77.7M added.
  • The largest Charles River Laboratories seller in Q4 2014 was Wellington Management Group, an estimated $16.6M sold.

Based on aggregated 13F filings for Q4 2014.